Aura Biosciences
USEntry
2015
Hold
6yr
Exit
2021
Who owns Aura Biosciences?
Aura Biosciences was owned by Ysios Capital Partners through Ysios BioFund II Innvierte (2016 vintage) from 2015 to 2021, exited via IPO. Across its history, Aura Biosciences has been through 2 private equity ownership periods, detailed in the timeline below.
Hand-verified · updated 2026-08-03
Most recent investor
Ysios Capital PartnersYsios BioFund II Innvierte · 2016 · Life Sciences VC
2 ownership periods · full history below
Key facts
HQUS
SectorBiotech
StatusAcquired
Key takeaways
- ·Fully exited in 2021.
- ·Average hold across 2 realized cycles: 5 years.
Ownership history
2 ownership periods · co-invest detected
Exited
Last exited in 2021.
Co-invest · 2 holders · 2015 · 2021
Ysios Capital PartnersExited 2021
2015 · 2021(6yr) · Ysios BioFund II Innvierte · 2016 · Life Sciences VC
IPO
MOIC
–
Columbus Venture PartnersExited 2021
2018 · 2021(3yr) · Columbus Innvierte Life Science Fund I · 2016 · Life Sciences VC
IPO
MOIC
–
More from Ysios BioFund II Innvierte
Other portfolio companies in the same fund.
CHMore PE-backed in Biotech
Comparable biotech deals from other GPs.
UK
FranceTrack Aura Biosciences
Save this record to your watchlist and pick up your research where you left off. No spam.
Get the full record on Aura Biosciences.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
Already a member? Sign in
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue